Impact of travel distance on receipt of indicated adjuvant therapy in resected non–small cell lung cancer

Michael A. Eisenberg,Nathaniel Deboever, Alexander C. Mills,Matthew R. Egyud,Wayne L. Hofstetter,Reza J. Mehran,David C. Rice,Ravi Rajaram,Boris Sepesi,Stephen G. Swisher,Garrett L. Walsh,Ara A. Vaporciyan,Mara B. Antonoff

The Journal of thoracic and cardiovascular surgery（2023）

引用 0|浏览32

暂无评分

摘要

Travel distance >100 miles negatively impacts likelihood of receiving indicated adjuvant therapy in NSCLC. Indications for systemic therapy in earlier staged disease are rapidly expanding, and these findings bear heightened relevance as we aim to provide equitable access to all patients.

查看译文

关键词

non–small cell lung cancer,disparities,adjuvant therapy,pulmonary resection

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要